HEALTHSTAT NEWS
STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
European countries are taking divergent approaches to drug pricing, with the U.K. adopting industry-friendly policies under pressure from pharma companies and the Trump administration, while Germany proposes spending cuts and higher fees for the industry amid health budget deficits.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
- STAT+: A political contest in the U.K. could shake up drug pricing
- Pharmaceutical industry becomes geopolitical battleground as US threatens tariffs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- STAT+: Top U.S. officials pressured Germany to pay more for prescription drugs
- STEPHEN MOORE: Foreign drug price controls are a hidden tax on Americans